Viyash Scientific share news, announcements and annual reports
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Viyash Scientific Limited · Formerly Sequent Scientific · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1990 on BSE, Mar 2016 on NSE
Last close ₹218.39down ₹6.16 (2.74%)BSE ₹218.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹224.55.
30 Oct: open ₹224.59, high ₹225.84, low ₹217.35
52-week range of traded prices to 30 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,645 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,13,10753.2% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 5 of 12.
Feb 2024
6 Feb · Board meeting
5 Feb · Board meeting
Dec 2023
29 Dec · Updates
Nov 2023
29 Nov · Legal
The exchange asked on 28 Nov 2023
7 Nov · Results
6 Nov · Board meeting
6 Nov · Board meeting
3 Nov · Rating
Oct 2023
30 Oct · Analysts
30 Oct · Board meeting
Sep 2023
20 Sep · Meeting
15 Sep · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 14-Jul-2023, regarding discontinuation of operations at the Company's manufacturing unit located at Tarapur, Maharashtra. On basis of above the Company is required to clarify following: 1. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year; 2. Reasons for closure. The response of the Company is awaited.14 Sep · Board meeting
Aug 2023
30 Aug · Meeting
17 Aug · Corrigendum
16 Aug · Corrigendum
10 Aug · Results
4 Aug · Analysts
Jul 2023
May 2023
23 May · Results
23 May · Board meeting
17 May · Legal
The exchange asked on 16 May 2023
17 May · Analysts
Apr 2023
20 Apr · Legal
The exchange asked on 19 Apr 2023
Mar 2023
8 Mar · Updates
Feb 2023
14 Feb · Results
Dec 2022
Nov 2022
21 Nov · Related Party Transaction